Transplantation as a subfield of regenerative medicine

Abstract

Interview by Lauren Constable, Commissioning Editor

Giuseppe Orlando, MD, PhD, is a research scientist at the Nuffield Department of Surgical Sciences at the University of Oxford, in quality of Marie Curie International Outgoing Fellow. He obtained his degrees in medicine and general surgery from the Tor Vergata University of Rome (Italy), where he also obtained his PhD in transplant sciences. In addition, he trained at the Liver Unit of the Paul Brousse Hospital (Villejuif, France), at the General Surgery and Liver Transplant Unit of the Cliniques Saint Luc (Brussels, Belgium) and at the Wake Forest Institute for Regenerative Medicine (Winston Salem, NC, USA). He specialized in liver and kidney transplantation, and is currently specializing in engineering and regeneration of transplantable abdominal organs. His main fields of investigation are: minimal immunosuppression and clinical operational tolerance after abdominal organ transplantation; renal, pancreas, liver and intestinal bioengineering; the respinse of the immune system to bioengineered body parts. Dr. Orlando’s main achievements have been in the field of steroid-free immunosuppression, immunosuppression minimization and clinical tolerance after liver transplantation and is on the board and a regular reviewer for a number of journals. He has authored or coauthored several research papers, review articles and book chapters on liver and kidney transplantation and regenerative medicine.

▪ Financial & competing interests disclosure

Giuseppe Orlando, MD, PhD is recipient of the Marie Curie International Outgoing Fellowship POIF-GA-2008-221850, financed by the European Commission under the 7th Framework Program for Research and Development. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.